Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Dermavant
Pharma
Dermavant's Vtama excels in another trial in atopic dermatitis
Dermavant has released data from a trial of Vtama that bolster its case for an approval in eczema, which would triple its eligible patient population.
Kevin Dunleavy
Jan 11, 2024 10:46am
Dermavant CEO draws Botox comparison to instill Vtama confidence
Nov 28, 2023 4:10pm
With Dermavant's Vtama struggling, Leerink slashes projections
Nov 14, 2023 11:13am
Dermavant strengthens approval bid for Vtama in eczema
Oct 12, 2023 8:50am
Incyte's Opzelura hits goal in eczema trial in young kids
Jul 12, 2023 10:30am
Dermavant bolsters Vtama's case for approval in eczema
May 16, 2023 8:25am